Baxter Issues Recall of Duo-Vent IV Administration Sets

WASHINGTON — Baxter is removing certain Duo-Vent solution sets from the U.S. market following a safety issue identified with the medical devices, according to the latest updates from the U.S. Food and Drug Administration.

The recall was listed by the FDA's Center for Devices and Radiological Health on August 13, 2026, placing the products among the latest medical-device safety actions being monitored by federal regulators.

Intravenous administration sets are commonly used by healthcare professionals to deliver fluids and medications to patients. Any defect involving such equipment can require hospitals and medical facilities to review inventories and follow manufacturer instructions.

Healthcare providers using potentially affected products are expected to check the FDA and manufacturer recall information and take appropriate action.

The recall adds to ongoing U.S. efforts to strengthen medical-device safety and prevent equipment-related risks in hospitals and clinical settings.